ASC Study Finds Colonoscopy Patients Prefer Propofol

Digital Debut

ASC Study Finds Colonoscopy Patients Prefer Propofol

The trial measured primary outcomes of patient satisfaction and procedure complications

BY SAHELY MUKERJI |  OCTOBER 2017

Results of a clinical trial conducted at an Ohio ASC show that patients prefer propofol over a combination of fentanyl/midazolam as their anesthetic for outpatient colonoscopies. From a patient and provider perspective, the researchers conclude, propofol appears to be superior to fentanyl/midazolam for outpatient colonoscopy.

 

To read this article, you have to be a member of ASCA or subscribe to ASC Focus magazine.

To become a member, click here. To subscribe to ASC Focus, click here.